Rare diseases
Investigational molecules
Locations
Ul. Barska 13, 87-800 Wloclawek, Poland
Centrum Diagnostyczno Lecznicze Barska Sp. z o.o. in Wloclawek, Poland specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, and other specialisations. This site conducts important research.
The department concentrates on innovative approaches for ulcerative colitis, a chronic inflammatory disorder of the colon.
At Centrum Diagnostyczno Lecznicze Barska, investigators are testing new medications to improve disease control and assess safety, aiming to broaden treatment options for patients with moderate to severe ulcerative colitis.
Clinical trials currently enrolling participants at this site.
Long-term safety study of tulisokibart in adults with Crohn's disease or ulcerative colitis
PolandStudy on BI 3032950 for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
PolandStudy of Tulisokibart for Patients with Moderately to Severely Active Ulcerative Colitis
PolandStudy on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis
PolandStudy on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis
PolandStudy of Oral NX-13 for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
PolandPolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
